Skip to main content
Clinical Trials/IRCT20210325050769N2
IRCT20210325050769N2
Completed
Phase 2

Evaluation of the efficacy and safety of an innovative flavonoid lotion in patients with hemorrhoid; A Randomized Clinical Trial

Bagheiat-allah University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Bagheiat-allah University of Medical Sciences
Enrollment
100
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bagheiat-allah University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Patients with grade 2 or higher hemorrhoids
  • Age range 18\-75
  • Lack of drug allergy to lotion
  • Lack of confounding underlying disease such as diabetes
  • Patient satisfaction

Exclusion Criteria

  • Patient dissatisfaction
  • Higher or lower grades of disease
  • Presence of drug allergy to plant Lotion
  • Existence of confounding underlying disease such as diabetes

Outcomes

Primary Outcomes

Not specified

Similar Trials